News and Press

On Saturday, 4 July 2026, the 21st Tyrolean Vaccination Day (Tiroler Impftag) takes place at the CCB in Innsbruck — a full-day continuing-education event on the latest developments in vaccination, co-organised by the Institute of Virology.

The Institute of Virology Innsbruck is hosting the official Kick-off Meeting of the EU-funded EAVI project (29 June – 01 July). The article provides an overview of the project’s goals and the launch of a European–African collaboration to advance vaccine development against neglected tropical diseases.

Barbara Falkensammer was awarded 3rd place in the poster competition at ISMD2026 in Graz. Her poster compared PCR detection methods for influenza, RSV, and SARS-CoV-2.

The June 2026 newsletter provides an epidemiological update on the Ebola outbreak caused by the Bundibugyo virus (BDBV) in the Democratic Republic of Congo and Uganda, declared a Public Health Emergency of International Concern (PHEIC) by the WHO on 17 May 2026. As of 12 June 2026, approximately 695 confirmed cases and 138 deaths have been recorded. Topics covered include the pathogen and its mortality, the current absence of approved vaccines or therapies for the Bundibugyo ebolavirus, ongoing development efforts, diagnostic criteria, and risk assessment for the EU/EEA.

A new EU project led by the Medical University of Innsbruck is testing a chikungunya vaccine approved in Europe in Africa.